Home Healthcare Biotechnology Infectious Disease Diagnostics Market

Infectious Disease Diagnostics Market Size, Share & Trends Analysis Report By Applications (Hepatitis, Human Immunodeficiency Virus (HIV), Chlamydia Trachomatis Genital Infection, Gonorrhea (CT/NG), Hospital-Acquired Infections, Human Papillomavirus (HPV), Tuberculosis (TB), Influenza), By Product (Assays, Kits, and Reagents, Instruments, Services and Software), By Technology (Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), Immunodiagnostics, DNA Microarray, Clinical Microbiology, DNA Sequencing and Next-Generation Sequencing (NGS)) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: May 25, 2026 | Author: Debashree B | Format: | Report Code: SR3537DR | Pages: 157
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Infectious Disease Diagnostics Market Size Analysis
    1. Introduction
    2. Infectious Disease Diagnostics Market Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
      1. Hepatitis
      2. Human Immunodeficiency Virus (HIV)
      3. Chlamydia Trachomatis Genital Infection
      4. Gonorrhea (CT/NG)
      5. Hospital-Acquired Infections
      6. Human Papillomavirus (HPV)
      7. Tuberculosis (TB)
      8. Influenza
    3. Infectious Disease Diagnostics Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Assays, Kits, and Reagents
      2. Instruments
      3. Services and Software
    4. Infectious Disease Diagnostics Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Polymerase Chain Reaction (PCR)
      2. Isothermal Nucleic Acid Amplification Technology (INAAT)
      3. Immunodiagnostics
      4. DNA Microarray
      5. Clinical Microbiology
      6. DNA Sequencing and Next-Generation Sequencing (NGS)
  7. North America Infectious Disease Diagnostics Market Size Analysis
    1. Introduction
    2. Infectious Disease Diagnostics Market Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
      1. Hepatitis
      2. Human Immunodeficiency Virus (HIV)
      3. Chlamydia Trachomatis Genital Infection
      4. Gonorrhea (CT/NG)
      5. Hospital-Acquired Infections
      6. Human Papillomavirus (HPV)
      7. Tuberculosis (TB)
      8. Influenza
    3. Infectious Disease Diagnostics Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Assays, Kits, and Reagents
      2. Instruments
      3. Services and Software
    4. Infectious Disease Diagnostics Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Polymerase Chain Reaction (PCR)
      2. Isothermal Nucleic Acid Amplification Technology (INAAT)
      3. Immunodiagnostics
      4. DNA Microarray
      5. Clinical Microbiology
      6. DNA Sequencing and Next-Generation Sequencing (NGS)
    5. U.S.
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Hepatitis
        2. Human Immunodeficiency Virus (HIV)
        3. Chlamydia Trachomatis Genital Infection
        4. Gonorrhea (CT/NG)
        5. Hospital-Acquired Infections
        6. Human Papillomavirus (HPV)
        7. Tuberculosis (TB)
        8. Influenza
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Instruments
        3. Services and Software
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Isothermal Nucleic Acid Amplification Technology (INAAT)
        3. Immunodiagnostics
        4. DNA Microarray
        5. Clinical Microbiology
        6. DNA Sequencing and Next-Generation Sequencing (NGS)
    6. Canada
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Hepatitis
        2. Human Immunodeficiency Virus (HIV)
        3. Chlamydia Trachomatis Genital Infection
        4. Gonorrhea (CT/NG)
        5. Hospital-Acquired Infections
        6. Human Papillomavirus (HPV)
        7. Tuberculosis (TB)
        8. Influenza
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Instruments
        3. Services and Software
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Isothermal Nucleic Acid Amplification Technology (INAAT)
        3. Immunodiagnostics
        4. DNA Microarray
        5. Clinical Microbiology
        6. DNA Sequencing and Next-Generation Sequencing (NGS)
  8. Europe Infectious Disease Diagnostics Market Size Analysis
    1. Introduction
    2. Infectious Disease Diagnostics Market Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
      1. Hepatitis
      2. Human Immunodeficiency Virus (HIV)
      3. Chlamydia Trachomatis Genital Infection
      4. Gonorrhea (CT/NG)
      5. Hospital-Acquired Infections
      6. Human Papillomavirus (HPV)
      7. Tuberculosis (TB)
      8. Influenza
    3. Infectious Disease Diagnostics Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Assays, Kits, and Reagents
      2. Instruments
      3. Services and Software
    4. Infectious Disease Diagnostics Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Polymerase Chain Reaction (PCR)
      2. Isothermal Nucleic Acid Amplification Technology (INAAT)
      3. Immunodiagnostics
      4. DNA Microarray
      5. Clinical Microbiology
      6. DNA Sequencing and Next-Generation Sequencing (NGS)
    5. U.K.
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Hepatitis
        2. Human Immunodeficiency Virus (HIV)
        3. Chlamydia Trachomatis Genital Infection
        4. Gonorrhea (CT/NG)
        5. Hospital-Acquired Infections
        6. Human Papillomavirus (HPV)
        7. Tuberculosis (TB)
        8. Influenza
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Instruments
        3. Services and Software
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Isothermal Nucleic Acid Amplification Technology (INAAT)
        3. Immunodiagnostics
        4. DNA Microarray
        5. Clinical Microbiology
        6. DNA Sequencing and Next-Generation Sequencing (NGS)
    6. Germany
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Hepatitis
        2. Human Immunodeficiency Virus (HIV)
        3. Chlamydia Trachomatis Genital Infection
        4. Gonorrhea (CT/NG)
        5. Hospital-Acquired Infections
        6. Human Papillomavirus (HPV)
        7. Tuberculosis (TB)
        8. Influenza
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Instruments
        3. Services and Software
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Isothermal Nucleic Acid Amplification Technology (INAAT)
        3. Immunodiagnostics
        4. DNA Microarray
        5. Clinical Microbiology
        6. DNA Sequencing and Next-Generation Sequencing (NGS)
    7. France
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Hepatitis
        2. Human Immunodeficiency Virus (HIV)
        3. Chlamydia Trachomatis Genital Infection
        4. Gonorrhea (CT/NG)
        5. Hospital-Acquired Infections
        6. Human Papillomavirus (HPV)
        7. Tuberculosis (TB)
        8. Influenza
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Instruments
        3. Services and Software
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Isothermal Nucleic Acid Amplification Technology (INAAT)
        3. Immunodiagnostics
        4. DNA Microarray
        5. Clinical Microbiology
        6. DNA Sequencing and Next-Generation Sequencing (NGS)
    8. Spain
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Hepatitis
        2. Human Immunodeficiency Virus (HIV)
        3. Chlamydia Trachomatis Genital Infection
        4. Gonorrhea (CT/NG)
        5. Hospital-Acquired Infections
        6. Human Papillomavirus (HPV)
        7. Tuberculosis (TB)
        8. Influenza
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Instruments
        3. Services and Software
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Isothermal Nucleic Acid Amplification Technology (INAAT)
        3. Immunodiagnostics
        4. DNA Microarray
        5. Clinical Microbiology
        6. DNA Sequencing and Next-Generation Sequencing (NGS)
    9. Italy
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Hepatitis
        2. Human Immunodeficiency Virus (HIV)
        3. Chlamydia Trachomatis Genital Infection
        4. Gonorrhea (CT/NG)
        5. Hospital-Acquired Infections
        6. Human Papillomavirus (HPV)
        7. Tuberculosis (TB)
        8. Influenza
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Instruments
        3. Services and Software
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Isothermal Nucleic Acid Amplification Technology (INAAT)
        3. Immunodiagnostics
        4. DNA Microarray
        5. Clinical Microbiology
        6. DNA Sequencing and Next-Generation Sequencing (NGS)
    10. Russia
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Hepatitis
        2. Human Immunodeficiency Virus (HIV)
        3. Chlamydia Trachomatis Genital Infection
        4. Gonorrhea (CT/NG)
        5. Hospital-Acquired Infections
        6. Human Papillomavirus (HPV)
        7. Tuberculosis (TB)
        8. Influenza
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Instruments
        3. Services and Software
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Isothermal Nucleic Acid Amplification Technology (INAAT)
        3. Immunodiagnostics
        4. DNA Microarray
        5. Clinical Microbiology
        6. DNA Sequencing and Next-Generation Sequencing (NGS)
    11. Nordic
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Hepatitis
        2. Human Immunodeficiency Virus (HIV)
        3. Chlamydia Trachomatis Genital Infection
        4. Gonorrhea (CT/NG)
        5. Hospital-Acquired Infections
        6. Human Papillomavirus (HPV)
        7. Tuberculosis (TB)
        8. Influenza
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Instruments
        3. Services and Software
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Isothermal Nucleic Acid Amplification Technology (INAAT)
        3. Immunodiagnostics
        4. DNA Microarray
        5. Clinical Microbiology
        6. DNA Sequencing and Next-Generation Sequencing (NGS)
    12. Benelux
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Hepatitis
        2. Human Immunodeficiency Virus (HIV)
        3. Chlamydia Trachomatis Genital Infection
        4. Gonorrhea (CT/NG)
        5. Hospital-Acquired Infections
        6. Human Papillomavirus (HPV)
        7. Tuberculosis (TB)
        8. Influenza
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Instruments
        3. Services and Software
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Isothermal Nucleic Acid Amplification Technology (INAAT)
        3. Immunodiagnostics
        4. DNA Microarray
        5. Clinical Microbiology
        6. DNA Sequencing and Next-Generation Sequencing (NGS)
    13. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Hepatitis
        2. Human Immunodeficiency Virus (HIV)
        3. Chlamydia Trachomatis Genital Infection
        4. Gonorrhea (CT/NG)
        5. Hospital-Acquired Infections
        6. Human Papillomavirus (HPV)
        7. Tuberculosis (TB)
        8. Influenza
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Instruments
        3. Services and Software
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Isothermal Nucleic Acid Amplification Technology (INAAT)
        3. Immunodiagnostics
        4. DNA Microarray
        5. Clinical Microbiology
        6. DNA Sequencing and Next-Generation Sequencing (NGS)
  9. APAC Infectious Disease Diagnostics Market Size Analysis
    1. Introduction
    2. Infectious Disease Diagnostics Market Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
      1. Hepatitis
      2. Human Immunodeficiency Virus (HIV)
      3. Chlamydia Trachomatis Genital Infection
      4. Gonorrhea (CT/NG)
      5. Hospital-Acquired Infections
      6. Human Papillomavirus (HPV)
      7. Tuberculosis (TB)
      8. Influenza
    3. Infectious Disease Diagnostics Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Assays, Kits, and Reagents
      2. Instruments
      3. Services and Software
    4. Infectious Disease Diagnostics Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Polymerase Chain Reaction (PCR)
      2. Isothermal Nucleic Acid Amplification Technology (INAAT)
      3. Immunodiagnostics
      4. DNA Microarray
      5. Clinical Microbiology
      6. DNA Sequencing and Next-Generation Sequencing (NGS)
    5. China
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Hepatitis
        2. Human Immunodeficiency Virus (HIV)
        3. Chlamydia Trachomatis Genital Infection
        4. Gonorrhea (CT/NG)
        5. Hospital-Acquired Infections
        6. Human Papillomavirus (HPV)
        7. Tuberculosis (TB)
        8. Influenza
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Instruments
        3. Services and Software
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Isothermal Nucleic Acid Amplification Technology (INAAT)
        3. Immunodiagnostics
        4. DNA Microarray
        5. Clinical Microbiology
        6. DNA Sequencing and Next-Generation Sequencing (NGS)
    6. Korea
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Hepatitis
        2. Human Immunodeficiency Virus (HIV)
        3. Chlamydia Trachomatis Genital Infection
        4. Gonorrhea (CT/NG)
        5. Hospital-Acquired Infections
        6. Human Papillomavirus (HPV)
        7. Tuberculosis (TB)
        8. Influenza
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Instruments
        3. Services and Software
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Isothermal Nucleic Acid Amplification Technology (INAAT)
        3. Immunodiagnostics
        4. DNA Microarray
        5. Clinical Microbiology
        6. DNA Sequencing and Next-Generation Sequencing (NGS)
    7. Japan
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Hepatitis
        2. Human Immunodeficiency Virus (HIV)
        3. Chlamydia Trachomatis Genital Infection
        4. Gonorrhea (CT/NG)
        5. Hospital-Acquired Infections
        6. Human Papillomavirus (HPV)
        7. Tuberculosis (TB)
        8. Influenza
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Instruments
        3. Services and Software
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Isothermal Nucleic Acid Amplification Technology (INAAT)
        3. Immunodiagnostics
        4. DNA Microarray
        5. Clinical Microbiology
        6. DNA Sequencing and Next-Generation Sequencing (NGS)
    8. India
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Hepatitis
        2. Human Immunodeficiency Virus (HIV)
        3. Chlamydia Trachomatis Genital Infection
        4. Gonorrhea (CT/NG)
        5. Hospital-Acquired Infections
        6. Human Papillomavirus (HPV)
        7. Tuberculosis (TB)
        8. Influenza
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Instruments
        3. Services and Software
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Isothermal Nucleic Acid Amplification Technology (INAAT)
        3. Immunodiagnostics
        4. DNA Microarray
        5. Clinical Microbiology
        6. DNA Sequencing and Next-Generation Sequencing (NGS)
    9. Australia
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Hepatitis
        2. Human Immunodeficiency Virus (HIV)
        3. Chlamydia Trachomatis Genital Infection
        4. Gonorrhea (CT/NG)
        5. Hospital-Acquired Infections
        6. Human Papillomavirus (HPV)
        7. Tuberculosis (TB)
        8. Influenza
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Instruments
        3. Services and Software
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Isothermal Nucleic Acid Amplification Technology (INAAT)
        3. Immunodiagnostics
        4. DNA Microarray
        5. Clinical Microbiology
        6. DNA Sequencing and Next-Generation Sequencing (NGS)
    10. Taiwan
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Hepatitis
        2. Human Immunodeficiency Virus (HIV)
        3. Chlamydia Trachomatis Genital Infection
        4. Gonorrhea (CT/NG)
        5. Hospital-Acquired Infections
        6. Human Papillomavirus (HPV)
        7. Tuberculosis (TB)
        8. Influenza
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Instruments
        3. Services and Software
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Isothermal Nucleic Acid Amplification Technology (INAAT)
        3. Immunodiagnostics
        4. DNA Microarray
        5. Clinical Microbiology
        6. DNA Sequencing and Next-Generation Sequencing (NGS)
    11. South East Asia
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Hepatitis
        2. Human Immunodeficiency Virus (HIV)
        3. Chlamydia Trachomatis Genital Infection
        4. Gonorrhea (CT/NG)
        5. Hospital-Acquired Infections
        6. Human Papillomavirus (HPV)
        7. Tuberculosis (TB)
        8. Influenza
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Instruments
        3. Services and Software
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Isothermal Nucleic Acid Amplification Technology (INAAT)
        3. Immunodiagnostics
        4. DNA Microarray
        5. Clinical Microbiology
        6. DNA Sequencing and Next-Generation Sequencing (NGS)
    12. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Hepatitis
        2. Human Immunodeficiency Virus (HIV)
        3. Chlamydia Trachomatis Genital Infection
        4. Gonorrhea (CT/NG)
        5. Hospital-Acquired Infections
        6. Human Papillomavirus (HPV)
        7. Tuberculosis (TB)
        8. Influenza
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Instruments
        3. Services and Software
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Isothermal Nucleic Acid Amplification Technology (INAAT)
        3. Immunodiagnostics
        4. DNA Microarray
        5. Clinical Microbiology
        6. DNA Sequencing and Next-Generation Sequencing (NGS)
  10. Middle East and Africa Infectious Disease Diagnostics Market Size Analysis
    1. Introduction
    2. Infectious Disease Diagnostics Market Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
      1. Hepatitis
      2. Human Immunodeficiency Virus (HIV)
      3. Chlamydia Trachomatis Genital Infection
      4. Gonorrhea (CT/NG)
      5. Hospital-Acquired Infections
      6. Human Papillomavirus (HPV)
      7. Tuberculosis (TB)
      8. Influenza
    3. Infectious Disease Diagnostics Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Assays, Kits, and Reagents
      2. Instruments
      3. Services and Software
    4. Infectious Disease Diagnostics Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Polymerase Chain Reaction (PCR)
      2. Isothermal Nucleic Acid Amplification Technology (INAAT)
      3. Immunodiagnostics
      4. DNA Microarray
      5. Clinical Microbiology
      6. DNA Sequencing and Next-Generation Sequencing (NGS)
    5. UAE
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Hepatitis
        2. Human Immunodeficiency Virus (HIV)
        3. Chlamydia Trachomatis Genital Infection
        4. Gonorrhea (CT/NG)
        5. Hospital-Acquired Infections
        6. Human Papillomavirus (HPV)
        7. Tuberculosis (TB)
        8. Influenza
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Instruments
        3. Services and Software
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Isothermal Nucleic Acid Amplification Technology (INAAT)
        3. Immunodiagnostics
        4. DNA Microarray
        5. Clinical Microbiology
        6. DNA Sequencing and Next-Generation Sequencing (NGS)
    6. Turkey
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Hepatitis
        2. Human Immunodeficiency Virus (HIV)
        3. Chlamydia Trachomatis Genital Infection
        4. Gonorrhea (CT/NG)
        5. Hospital-Acquired Infections
        6. Human Papillomavirus (HPV)
        7. Tuberculosis (TB)
        8. Influenza
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Instruments
        3. Services and Software
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Isothermal Nucleic Acid Amplification Technology (INAAT)
        3. Immunodiagnostics
        4. DNA Microarray
        5. Clinical Microbiology
        6. DNA Sequencing and Next-Generation Sequencing (NGS)
    7. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Hepatitis
        2. Human Immunodeficiency Virus (HIV)
        3. Chlamydia Trachomatis Genital Infection
        4. Gonorrhea (CT/NG)
        5. Hospital-Acquired Infections
        6. Human Papillomavirus (HPV)
        7. Tuberculosis (TB)
        8. Influenza
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Instruments
        3. Services and Software
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Isothermal Nucleic Acid Amplification Technology (INAAT)
        3. Immunodiagnostics
        4. DNA Microarray
        5. Clinical Microbiology
        6. DNA Sequencing and Next-Generation Sequencing (NGS)
    8. South Africa
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Hepatitis
        2. Human Immunodeficiency Virus (HIV)
        3. Chlamydia Trachomatis Genital Infection
        4. Gonorrhea (CT/NG)
        5. Hospital-Acquired Infections
        6. Human Papillomavirus (HPV)
        7. Tuberculosis (TB)
        8. Influenza
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Instruments
        3. Services and Software
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Isothermal Nucleic Acid Amplification Technology (INAAT)
        3. Immunodiagnostics
        4. DNA Microarray
        5. Clinical Microbiology
        6. DNA Sequencing and Next-Generation Sequencing (NGS)
    9. Egypt
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Hepatitis
        2. Human Immunodeficiency Virus (HIV)
        3. Chlamydia Trachomatis Genital Infection
        4. Gonorrhea (CT/NG)
        5. Hospital-Acquired Infections
        6. Human Papillomavirus (HPV)
        7. Tuberculosis (TB)
        8. Influenza
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Instruments
        3. Services and Software
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Isothermal Nucleic Acid Amplification Technology (INAAT)
        3. Immunodiagnostics
        4. DNA Microarray
        5. Clinical Microbiology
        6. DNA Sequencing and Next-Generation Sequencing (NGS)
    10. Nigeria
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Hepatitis
        2. Human Immunodeficiency Virus (HIV)
        3. Chlamydia Trachomatis Genital Infection
        4. Gonorrhea (CT/NG)
        5. Hospital-Acquired Infections
        6. Human Papillomavirus (HPV)
        7. Tuberculosis (TB)
        8. Influenza
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Instruments
        3. Services and Software
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Isothermal Nucleic Acid Amplification Technology (INAAT)
        3. Immunodiagnostics
        4. DNA Microarray
        5. Clinical Microbiology
        6. DNA Sequencing and Next-Generation Sequencing (NGS)
    11. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Hepatitis
        2. Human Immunodeficiency Virus (HIV)
        3. Chlamydia Trachomatis Genital Infection
        4. Gonorrhea (CT/NG)
        5. Hospital-Acquired Infections
        6. Human Papillomavirus (HPV)
        7. Tuberculosis (TB)
        8. Influenza
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Instruments
        3. Services and Software
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Isothermal Nucleic Acid Amplification Technology (INAAT)
        3. Immunodiagnostics
        4. DNA Microarray
        5. Clinical Microbiology
        6. DNA Sequencing and Next-Generation Sequencing (NGS)
  11. LATAM Infectious Disease Diagnostics Market Size Analysis
    1. Introduction
    2. Infectious Disease Diagnostics Market Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
      1. Hepatitis
      2. Human Immunodeficiency Virus (HIV)
      3. Chlamydia Trachomatis Genital Infection
      4. Gonorrhea (CT/NG)
      5. Hospital-Acquired Infections
      6. Human Papillomavirus (HPV)
      7. Tuberculosis (TB)
      8. Influenza
    3. Infectious Disease Diagnostics Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Assays, Kits, and Reagents
      2. Instruments
      3. Services and Software
    4. Infectious Disease Diagnostics Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Polymerase Chain Reaction (PCR)
      2. Isothermal Nucleic Acid Amplification Technology (INAAT)
      3. Immunodiagnostics
      4. DNA Microarray
      5. Clinical Microbiology
      6. DNA Sequencing and Next-Generation Sequencing (NGS)
    5. Brazil
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Hepatitis
        2. Human Immunodeficiency Virus (HIV)
        3. Chlamydia Trachomatis Genital Infection
        4. Gonorrhea (CT/NG)
        5. Hospital-Acquired Infections
        6. Human Papillomavirus (HPV)
        7. Tuberculosis (TB)
        8. Influenza
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Instruments
        3. Services and Software
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Isothermal Nucleic Acid Amplification Technology (INAAT)
        3. Immunodiagnostics
        4. DNA Microarray
        5. Clinical Microbiology
        6. DNA Sequencing and Next-Generation Sequencing (NGS)
    6. Mexico
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Hepatitis
        2. Human Immunodeficiency Virus (HIV)
        3. Chlamydia Trachomatis Genital Infection
        4. Gonorrhea (CT/NG)
        5. Hospital-Acquired Infections
        6. Human Papillomavirus (HPV)
        7. Tuberculosis (TB)
        8. Influenza
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Instruments
        3. Services and Software
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Isothermal Nucleic Acid Amplification Technology (INAAT)
        3. Immunodiagnostics
        4. DNA Microarray
        5. Clinical Microbiology
        6. DNA Sequencing and Next-Generation Sequencing (NGS)
    7. Argentina
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Hepatitis
        2. Human Immunodeficiency Virus (HIV)
        3. Chlamydia Trachomatis Genital Infection
        4. Gonorrhea (CT/NG)
        5. Hospital-Acquired Infections
        6. Human Papillomavirus (HPV)
        7. Tuberculosis (TB)
        8. Influenza
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Instruments
        3. Services and Software
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Isothermal Nucleic Acid Amplification Technology (INAAT)
        3. Immunodiagnostics
        4. DNA Microarray
        5. Clinical Microbiology
        6. DNA Sequencing and Next-Generation Sequencing (NGS)
    8. Chile
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Hepatitis
        2. Human Immunodeficiency Virus (HIV)
        3. Chlamydia Trachomatis Genital Infection
        4. Gonorrhea (CT/NG)
        5. Hospital-Acquired Infections
        6. Human Papillomavirus (HPV)
        7. Tuberculosis (TB)
        8. Influenza
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Instruments
        3. Services and Software
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Isothermal Nucleic Acid Amplification Technology (INAAT)
        3. Immunodiagnostics
        4. DNA Microarray
        5. Clinical Microbiology
        6. DNA Sequencing and Next-Generation Sequencing (NGS)
    9. Colombia
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Hepatitis
        2. Human Immunodeficiency Virus (HIV)
        3. Chlamydia Trachomatis Genital Infection
        4. Gonorrhea (CT/NG)
        5. Hospital-Acquired Infections
        6. Human Papillomavirus (HPV)
        7. Tuberculosis (TB)
        8. Influenza
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Instruments
        3. Services and Software
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Isothermal Nucleic Acid Amplification Technology (INAAT)
        3. Immunodiagnostics
        4. DNA Microarray
        5. Clinical Microbiology
        6. DNA Sequencing and Next-Generation Sequencing (NGS)
    10. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Hepatitis
        2. Human Immunodeficiency Virus (HIV)
        3. Chlamydia Trachomatis Genital Infection
        4. Gonorrhea (CT/NG)
        5. Hospital-Acquired Infections
        6. Human Papillomavirus (HPV)
        7. Tuberculosis (TB)
        8. Influenza
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Instruments
        3. Services and Software
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Isothermal Nucleic Acid Amplification Technology (INAAT)
        3. Immunodiagnostics
        4. DNA Microarray
        5. Clinical Microbiology
        6. DNA Sequencing and Next-Generation Sequencing (NGS)
  12. Competitive Landscape
    1. Infectious Disease Diagnostics Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Biomerieux Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Abbott Laboratories
    3. Becton, Dickinson and Company
    4. Bio-Rad Laboratories Inc.
    5. Danaher Corporation
    6. F. Hoffmann-La Roche Ag
    7. Siemens Healthcare Gmbh
    8. Thermo Fisher Scientific Inc
    9. Quidel Corporation
    10. Diasorin Spa (Luminex Corporation)
    11. Trinity Biotech Plc
    12. Quest Diagnostics
    13. Sysmex Corporation
    14. Ortho-Clinical Diagnostics
    15. Seegene Inc
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.